Long-term depression of two primary immune responses induced by a single dose of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC)

Plaque Forming Cells: Methodology and Theory

1974 • 290 citations

IMMUNOLOGICAL ALTERNATION OF LEUKEMIC CELLS In Vivo AFTER TREATMENT WITH AN ANTITUMOR DRUG

1970 • 121 citations

Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.

1972 • 71 citations

LOSS OF SKIN ALLOGRAFT TOLERANCE BY CHIMERAS

1968 • 52 citations

Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.

1969 • 51 citations

Cellular immune response to a drug-treated L5178Y lymphoma subline

1974 • 49 citations

Some Pharmacokinetic Aspects of 5-(Dimethyltriazeno)-imidazole-4-carboxamide in the Dog

1968 • 37 citations

Brief Communication: Increased Immunogenicity of Two Lymphoma Lines After Drug Treatment of Athymic (Nude) Mice

1975 • 30 citations

THE IMMUNODEPRESSIVE AND HEMATOTOXIC ACTIVITY OF IMIDAZOLE-4-CARBOXAMIDE,5-(3,3-DIMETHYL-1-TRIAZENO) IN MICE

1976 • 25 citations

Immunopharmacology of 5-(3,3-dIMETHYL-1-triazeno)-imidazole-4-carboxamide (DTIC) (DTIC)

1975 • 17 citations

Antigenic change in l1210 leukemic cells induced in vivo by two drugs. Abstr.

1971 • 1 citations